.After a year defined by pipe hairstyles, the departure of its own CEO and unemployments, Exscientia...
.Cullinan Therapeutics was actually excited sufficient with Port BioMed's bispecific immune reactor ...
.In this week's episode of "The Leading Pipe," our experts are actually diving into Fierce Biotech's...
.The confetti is still soaring coming from Eli Lilly's party commemorating the commendation of Alzhe...
.Invite to today's Chutes & Ladders, our summary of considerable management hirings, shootings an...
.Observing a bad revealing for Lykos Therapeutics' MDMA prospect for trauma at a latest FDA advising...
.AN2 Therapies is actually reviewing its company in action to uninspired midphase data, pledging to ...
.Merck & Co. is actually paying for $700 million upfront to test Amgen in a blood cancer cells ma...
.Along With Gilead Sciences about to an FDA decision for its own liver illness medication seladelpar...
.CEO David Ricks may see the providers establishing tents at basecamp behind Eli Lilly in a try to g...